Nicole Dale

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

Read Foundational AI In Cell and Gene Therapy Development Success
- Cell and Gene Therapy
- Next-gen Modalities
- AI Drug Development
- AI & Machine Learning
- AI and Automation
- AI Drug Discovery
- AI Pharma
- Artificial Intelligence in Healthcare
- Continuous Manufacturing
- Decentralised Manufacturing
- Drug Delivery
- Drug Production
- Rare Diseases
- Orphan Drugs
- Oncology
- Immunology and Immunotherapy
- Quality
- Pharmaceutical Compliance
- Pharma Regulation
- Pharma Policy
Foundational AI In Cell and Gene Therapy Development Success
Read Success for Non-Animal Testing of Preclinical Toxicity?
- Preclinical Development
- Drug Discovery
- AI Drug Discovery
- Biomedical R&D
- Pharmaceutical R&D
- Pharma Regulation
Success for Non-Animal Testing of Preclinical Toxicity?
Read Eli Lilly and AtaiBeckley: AI and Psychedelic Biotech Converge
- Neurological Disease
- AI Drug Discovery
- AI Drug Development
- AI & Machine Learning
- AI Pharma
- Tech and Innovation
- Investment and Market Analysis
Eli Lilly and AtaiBeckley: AI and Psychedelic Biotech Converge
Read Why CMC Strategy Defines Cell and Gene Therapy Success
- CMC
- Cell and Gene Therapy
- Next-gen Modalities
- Quality
- Pharmaceutical Compliance
- Pharma Regulation
- Pharma Policy
- Rare Diseases
- Oncology
- Decentralised Manufacturing
- Continuous Manufacturing
- Sterile Manufacturing
Why CMC Strategy Defines Cell and Gene Therapy Success